academic article

• Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018..  American journal of epidemiology.  2024
• Autoimmune disease and risk of postpartum venous thromboembolism..  Research and practice in thrombosis and haemostasis.  7:-. 2023
• Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database..  BMC cardiovascular disorders.  21:-. 2021
• Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018..  Journal of the American Heart Association.  10:-. 2021
• Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism..  Journal of the American Heart Association.  10:-. 2021
• Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation..  JAMA internal medicine.  180:245-253. 2020
• Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data..  Epidemiology (Cambridge, Mass.).  30:885-892. 2019
• Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation..  PloS one.  14:-. 2019
• Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism..  British journal of haematology.  185:903-911. 2019
• A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants..  Heart rhythm.  16:820-826. 2018
• Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients..  Current medical research and opinion.  35:837-845. 2018
• Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation..  Journal of the American Heart Association.  7:-. 2018
• Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer..  Journal of the American College of Cardiology.  72:1913-1922. 2018
• A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants..  PloS one.  13:-. 2018
• Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation..  The American journal of cardiology.  122:388-394. 2018
• Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation..  Journal of the American Heart Association.  7. 2018
• Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation..  Blood advances.  2:200-209. 2018
• Oral anticoagulants and liver injury: the threat of uncontrolled confounding..  Heart (British Cardiac Society).  104:-. 2018
• Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation..  BMC cardiovascular disorders.  17:-. 2017
• Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation..  Heart (British Cardiac Society).  103:834-839. 2017
• Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)..  PloS one.  11:-. 2016